A framework for extremely multiplexed dextramer mapping and prediction of T cell receptor sequences to antigen specificity
T cell receptor (TCR) antigen-specific recognition is important for the adaptive immune system. Nevertheless, constructing a TCR-antigen interplay map has been difficult because of the staggering range of TCRs and antigens. Accordingly, extremely multiplexed dextramer-TCR binding assays have been just lately developed, however the utility of the following giant datasets is restricted by the shortage of sturdy computational strategies for normalization and interpretation.
Right here, we current a computational framework comprising a novel technique, ICON (Integrative COntext-specific Normalization), for figuring out dependable TCR-pMHC (peptide-major histocompatibility complicated) interactions and a neural network-based classifier TCRAI that outperforms different state-of-the-art strategies for TCR-antigen specificity prediction. We additional demonstrated that by combining ICON and TCRAI, we’re capable of uncover novel subgroups of TCRs that bind to a given pMHC through totally different mechanisms. Our framework facilitates the identification and understanding of TCR-antigen-specific interactions for fundamental immunological analysis and medical immune monitoring.
Quantifying persistence within the T-cell signaling community utilizing an optically controllable antigen receptor
T cells discriminate between wholesome and contaminated cells with outstanding sensitivity when mounting an immune response, which is hypothesized to rely on T cells combining stimuli from a number of antigen-presenting cell interactions right into a stronger response. To quantify the capability for T cells to perform this, we now have developed an antigen receptor that’s optically tunable inside cell conjugates, offering management over the length, and depth of intracellular T-cell signaling.
We observe restricted persistence inside the T-cell intracellular community on disruption of receptor enter, with indicators dissipating solely in ~15 min, and straight present sustained proximal receptor signaling is required to keep up gene transcription. T cells thus primarily accumulate the outputs of gene expression slightly than combine discrete intracellular indicators. Engineering optical management in a clinically related chimeric antigen receptor (CAR), we present that this restricted sign persistence will be exploited to extend CAR-T cell activation threefold utilizing pulsatile stimulation. Our outcomes are prone to apply extra typically to the signaling dynamics of different mobile networks.
Tumor rejection properties of gp100 209-specific T cells correlate with T cell receptor binding affinity in direction of the wild sort slightly than anchor-modified antigen
Though there are exceptions and outliers, T cell useful responses typically correlate with the affinity of a TCR for a peptide/MHC complicated. In a single just lately described outlier case, essentially the most promising medical candidate in a sequence of TCRs particular for the gp100209 melanoma antigen certain with the weakest resolution affinity and produced the least quantity of cytokine in vitro. Hypotheses for this outlier conduct included uncommon cytokine expression patterns arising from an atypical TCR binding geometry. Learning this occasion in additional element, we discovered right here that outlier conduct is attributable to not uncommon cytokine patterns or TCR binding, however the usage of a place 2 anchor-modified peptide variant in in vitro experiments as an alternative of the wild sort antigen that’s current in vivo.
Though the anchor-modified variant has been extensively utilized in fundamental and medical immunology as a surrogate for the wild sort peptide, prior work has proven that TCRs can clearly distinguish between the 2. We present that when this differential recognition is accounted for, the useful properties of gp100209-specific TCRs observe with their affinity in direction of the peptide/MHC complicated. Past demonstrating the correlates with T cell operate for a clinically related TCR, our outcomes present necessary concerns for choice of TCRs for immunotherapy and the usage of modified peptides in immunology.
EBAG9 siRNA |
|||
| 20-abx914880 | Abbexa |
|
|
EBAG9 siRNA |
|||
| 20-abx901624 | Abbexa |
|
|
EBAG9 antibody |
|||
| 38323-100ul | SAB | 100ul | EUR 252 |
EBAG9 Antibody |
|||
| ABD6703 | Lifescience Market | 100 ug | EUR 438 |
EBAG9 Antibody |
|||
| DF6703 | Affbiotech | 200ul | EUR 304 |
|
Description: EBAG9 Antibody detects endogenous levels of total EBAG9. |
|||
EBAG9 Peptide |
|||
| 45-515P | ProSci | 0.1 mg | EUR 338 |
|
Description: EBAG9 / RCAS1 Peptide |
|||
EBAG9 antibody |
|||
| 70R-16981 | Fitzgerald | 50 ul | EUR 435 |
|
Description: Rabbit polyclonal EBAG9 antibody |
|||
EBAG9 antibody |
|||
| 70R-9916 | Fitzgerald | 50 ug | EUR 467 |
|
Description: Affinity purified rabbit polyclonal EBAG9 antibody |
|||
EBAG9 protein (His tag) |
|||
| 80R-1093 | Fitzgerald | 100 ug | EUR 224 |
|
Description: Purified recombinant Human EBAG9 protein |
|||
CMV (Cytomegalovirus Antibody IgG) ELISA test |
|||
| 28 | Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of CMV (Cytomegalovirus Antibody IgG) |
|||
Recombinant HPV-28 E1 Protein |
|||
| VAng-Wyb3131-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Human papillomavirus type 28 Replication protein E1, recombinant protein. |
|||
Recombinant HPV-28 L1 Protein |
|||
| VAng-Wyb3136-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Human papillomavirus type 28 Major capsid protein L1, recombinant protein. |
|||
RNU6-28 Recombinant Protein (Human) |
|||
| RP089073 | ABM | 100 ug | Ask for price |
EBAG9 cloning plasmid |
|||
| CSB-CL007355HU1-10ug | Cusabio | 10ug | EUR 233 |
|
Description: A cloning plasmid for the EBAG9 gene. |
|||
EBAG9 cloning plasmid |
|||
| CSB-CL007355HU2-10ug | Cusabio | 10ug | EUR 233 |
|
Description: A cloning plasmid for the EBAG9 gene. |
|||
Anti-EBAG9 Antibody |
|||
| PB9553 | BosterBio | 100ug/vial | EUR 334 |
Human EBAG9 Antibody |
|||
| 32605-05111 | AssayPro | 150 ug | EUR 261 |
Anti-EBAG9 antibody |
|||
| STJ23462 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. |
|||
Anti-EBAG9 antibody |
|||
| STJ110683 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor, which binds to the estrogen-responsive element found in the 5'-flanking region of this gene. The encoded protein is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. Alternate splicing results in multiple transcript variants. A pseudogene of this gene has been defined on chromosome 10. |
|||
EBAG9 Rabbit pAb |
|||
| A1935-100ul | Abclonal | 100 ul | EUR 308 |
EBAG9 Rabbit pAb |
|||
| A1935-200ul | Abclonal | 200 ul | EUR 459 |
EBAG9 Rabbit pAb |
|||
| A1935-20ul | Abclonal | 20 ul | EUR 183 |
EBAG9 Rabbit pAb |
|||
| A1935-50ul | Abclonal | 50 ul | EUR 223 |
EBAG9 Rabbit pAb |
|||
| A8385-100ul | Abclonal | 100 ul | EUR 308 |
EBAG9 Rabbit pAb |
|||
| A8385-200ul | Abclonal | 200 ul | EUR 459 |
EBAG9 Rabbit pAb |
|||
| A8385-20ul | Abclonal | 20 ul | Ask for price |
EBAG9 Rabbit pAb |
|||
| A8385-50ul | Abclonal | 50 ul | Ask for price |
EBAG9 Conjugated Antibody |
|||
| C38323 | SAB | 100ul | EUR 397 |
EBAG9 Blocking Peptide |
|||
| DF6703-BP | Affbiotech | 1mg | EUR 195 |
EBAG9 Blocking Peptide |
|||
| 33R-2039 | Fitzgerald | 100 ug | EUR 180 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of EBAG9 antibody, catalog no. 70R-9916 |
|||
pCMV-SPORT6-EBAG9 |
|||
| PVT13493 | Lifescience Market | 2 ug | EUR 391 |
Anti-EBAG9 (4A10) |
|||
| YF-MA16699 | Abfrontier | 100 ug | EUR 363 |
|
Description: Mouse monoclonal to EBAG9 |
|||
Recombinant Keratin 28 (KRT28) |
|||
| 4-RPS214Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Keratin 28 expressed in: E.coli |
|||
Matrix Metalloproteinase-28 (Recombinant) |
|||
| 20-abx073425 | Abbexa |
|
|
IL-28, human recombinant |
|||
| 4978-1000 | Biovision | EUR 5204 | |
IL-28, human recombinant |
|||
| 4978-20 | Biovision | EUR 294 | |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-100ug |
|||
| QP5959-ec-100ug | EnQuireBio | 100ug | EUR 408 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-10ug |
|||
| QP5959-ec-10ug | EnQuireBio | 10ug | EUR 200 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-1mg |
|||
| QP5959-ec-1mg | EnQuireBio | 1mg | EUR 1632 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-200ug |
|||
| QP5959-ec-200ug | EnQuireBio | 200ug | EUR 634 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-500ug |
|||
| QP5959-ec-500ug | EnQuireBio | 500ug | EUR 1060 |
Recombinant Human RCAS1/ EBAG9 Protein, His-SUMO, E.coli-50ug |
|||
| QP5959-ec-50ug | EnQuireBio | 50ug | EUR 263 |
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06871 | CHI Scientific | 10µg | Ask for price |
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06872 | CHI Scientific | 50µg | Ask for price |
Recombinant Human Vacuolar Protein Sorting 28 |
|||
| 7-06873 | CHI Scientific | 1mg | Ask for price |
Polyclonal EBAG9 Antibody (Center) |
|||
| APR04492G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EBAG9 (Center). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal EBAG9 Antibody (Center) |
|||
| APR06938G | Leading Biology | 0.1ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human EBAG9 (Center). This antibody is tested and proven to work in the following applications: |
|||
Rat EBAG9 shRNA Plasmid |
|||
| 20-abx989010 | Abbexa |
|
|
Mouse EBAG9 shRNA Plasmid |
|||
| 20-abx974569 | Abbexa |
|
|
Human EBAG9 shRNA Plasmid |
|||
| 20-abx956064 | Abbexa |
|
|
Anti-EBAG9 / RCAS1 antibody |
|||
| STJ70947 | St John's Laboratory | 100 µg | EUR 359 |
PRSS28 Protease Serine 28 Mouse Recombinant Protein |
|||
| PROTQ924N9 | BosterBio | Regular: 5ug | EUR 317 |
|
Description: PRSS28 Mouse Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 256 amino acids (27-274a.a.) and having a molecular mass of 28.7kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa)._x000D_PRSS28 is expressed with an 8 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques. |
|||
MMP28 Matrix Metalloproteinase-28 Human Recombinant Protein |
|||
| PROTQ9H239 | BosterBio | Regular: 20ug | EUR 317 |
|
Description: MMP28 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 421 amino acids (123-520a.a) and having a molecular mass of 47.3kDa. MMP28 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Recombinant Rat ALCAM Protein (aa 28-583) |
|||
| VAng-2940Lsx-100g | Creative Biolabs | 100 µg | EUR 7254 |
|
Description: Recombinant Rat ALCAM is expressed in cell free expression systems. (Uniprot ID: O35112) |
|||
Recombinant Rat ALCAM Protein (aa 28-583) |
|||
| VAng-2940Lsx-50g | Creative Biolabs | 50 µg | EUR 4765 |
|
Description: Recombinant Rat ALCAM is expressed in cell free expression systems. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-100g | Creative Biolabs | 100 µg | EUR 1150 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-1mg | Creative Biolabs | 1 mg | EUR 3913 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Rabbit ALCAM Protein (aa 28-527) |
|||
| VAng-2947Lsx-500g | Creative Biolabs | 500 µg | EUR 2663 |
|
Description: Recombinant Rabbit ALCAM is expressed in E. coli. (Uniprot ID: O35112) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-1mg | Creative Biolabs | 1 mg | EUR 3390 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-200g | Creative Biolabs | 200 µg | EUR 1370 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Human ALCAM Protein (aa 28-516) |
|||
| VAng-2950Lsx-500g | Creative Biolabs | 500 µg | EUR 2223 |
|
Description: Recombinant Human ALCAM is expressed in E. coli. (Uniprot ID: Q13740) |
|||
Recombinant Bovine ALCAM Protein (aa 28-527) |
|||
| VAng-2957Lsx-1mg | Creative Biolabs | 1 mg | EUR 5852 |
|
Description: Recombinant Bovine ALCAM is expressed in E. coli. (Uniprot ID: Q9BH13) |
|||
Recombinant Bovine ALCAM Protein (aa 28-527) |
|||
| VAng-2957Lsx-500g | Creative Biolabs | 500 µg | EUR 3583 |
|
Description: Recombinant Bovine ALCAM is expressed in E. coli. (Uniprot ID: Q9BH13) |
|||
Recombinant Mouse ALCAM Protein (aa 28-527) |
|||
| VAng-2959Lsx-500g | Creative Biolabs | 500 µg | EUR 6415 |
|
Description: Recombinant Mouse ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q61490) |
|||
Recombinant Mouse ALCAM Protein (aa 28-527) |
|||
| VAng-2959Lsx-50g | Creative Biolabs | 50 µg | EUR 1246 |
|
Description: Recombinant Mouse ALCAM is expressed in HEK 293 Cells. (Uniprot ID: Q61490) |
|||
Recombinant CD155 Protein (Asp 28-Asn 343) |
|||
| VAng-1181Lsx-100g | Creative Biolabs | 100 µg | EUR 1013 |
|
Description: Rhesus macaque CD155 is expressed in HEK 293 cells. (Uniprot ID: Q0MSE6-1) |
|||
Recombinant CD155 Protein (Asp 28-Asn 343) |
|||
| VAng-1181Lsx-1mg | Creative Biolabs | 1 mg | EUR 6402 |
|
Description: Rhesus macaque CD155 is expressed in HEK 293 cells. (Uniprot ID: Q0MSE6-1) |
|||
Recombinant Erythropoietin Protein (Ala 28-Arg 193) |
|||
| VAng-1516Lsx-20g | Creative Biolabs | 20 µg | EUR 594 |
|
Description: Human Erythropoietin (EPO) is expressed in HEK 293 cells. (Uniprot ID: AAH93628.1) |
|||
Recombinant Erythropoietin Protein (Ala 28-Arg 193) |
|||
| VAng-1516Lsx-50g | Creative Biolabs | 50 µg | EUR 1013 |
|
Description: Human Erythropoietin (EPO) is expressed in HEK 293 cells. (Uniprot ID: AAH93628.1) |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2577 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1747 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
Recombinant Salmonella leuL Protein (aa 1-28) |
|||
| VAng-Wyb0496-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1197 |
|
Description: Salmonella typhi Leu operon leader peptide, recombinant protein. |
|||
Insulin R / CD220 (28-944) Recombinant Protein |
|||
| 11-371 | ProSci | 0.1 mg | EUR 542.75 |
|
Description: Insulin receptor (INSR) is also known as CD antigen CD220, which can be cleaved into the following 2 chains: Insulin receptor subunit alpha and Insulin receptor subunit beta. INSR is a tetramer of 2 alpha and 2 beta chains linked by disulfide bonds. The alpha chains carry the insulin-binding regions, while the beta chains carry the kinase domain. Forms a hybrid receptor with IGF1R, the hybrid is a tetramer consisting of 1 alpha chain and 1 beta chain of INSR and 1 alpha chain and 1 beta chain of IGF1R. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short of INSR has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, INSR binds IGF1. |
|||
VPS28 Vacuolar Protein Sorting 28 Human Recombinant Protein |
|||
| PROTQ9UK41 | BosterBio | Regular: 50ug | EUR 317 |
|
Description: VPS28 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 221 amino acids (1-221 a.a.) and having a molecular mass of 25.4kDa.;The VPS28 is purified by proprietary chromatographic techniques. |
|||
EBAG9 Protein Vector (Human) (pPB-C-His) |
|||
| PV013461 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPB-N-His) |
|||
| PV013462 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPM-C-HA) |
|||
| PV013463 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPM-C-His) |
|||
| PV013464 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPB-C-His) |
|||
| PV013465 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPB-N-His) |
|||
| PV013466 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPM-C-HA) |
|||
| PV013467 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Human) (pPM-C-His) |
|||
| PV013468 | ABM | 500 ng | EUR 329 |
EBAG9 Protein Vector (Rat) (pPB-C-His) |
|||
| PV265294 | ABM | 500 ng | EUR 603 |
EBAG9 Protein Vector (Rat) (pPB-N-His) |
|||
| PV265295 | ABM | 500 ng | EUR 603 |
EBAG9 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV265296 | ABM | 500 ng | EUR 603 |
EBAG9 Protein Vector (Rat) (pPM-C-His) |
|||
| PV265297 | ABM | 500 ng | EUR 603 |
EBAG9 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV174238 | ABM | 500 ng | EUR 603 |
EBAG9 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV174239 | ABM | 500 ng | EUR 603 |
EBAG9 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV174240 | ABM | 500 ng | EUR 603 |
EBAG9 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV174241 | ABM | 500 ng | EUR 603 |
Human EBAG9 Antibody (Biotin Conjugate) |
|||
| 32605-05121 | AssayPro | 150 ug | EUR 369 |
EBAG9 ELISA Kit (Human) (OKEH05822) |
|||
| OKEH05822 | Aviva Systems Biology | 96 Wells | EUR 662 |
|
Description: Description of target: May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.39U/L |
|||
EBAG9 ELISA Kit (Human) (OKCA02302) |
|||
| OKCA02302 | Aviva Systems Biology | 96 Wells | EUR 930 |
|
Description: Description of target: May participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: 0.195 U/mL. |
|||
Ebag9 ORF Vector (Rat) (pORF) |
|||
| ORF066324 | ABM | 1.0 ug DNA | EUR 506 |
Ebag9 ORF Vector (Mouse) (pORF) |
|||
| ORF043560 | ABM | 1.0 ug DNA | EUR 506 |
EBAG9 ORF Vector (Human) (pORF) |
|||
| ORF003366 | ABM | 1.0 ug DNA | EUR 95 |
EBAG9 ORF Vector (Human) (pORF) |
|||
| ORF003367 | ABM | 1.0 ug DNA | EUR 95 |
WRG-28 |
|||
| HY-114169 | MedChemExpress | 1mg | EUR 108 |
Somatostatin-28 |
|||
| 5-01950 | CHI Scientific | 0.4 x 5mg | Ask for price |
Somatostatin-28 |
|||
| H-4955.0500 | Bachem | 0.5mg | EUR 393 |
|
Description: Sum Formula: C137H207N41O39S3; CAS# [73032-94-7] net |
|||
Somatostatin-28 |
|||
| H-4955.1000 | Bachem | 1.0mg | EUR 696 |
|
Description: Sum Formula: C137H207N41O39S3; CAS# [73032-94-7] net |
|||
SMER 28 |
|||
| B7637-10 | ApexBio | 10 mg | EUR 189 |
|
Description: IC50: N/ASMER 28 is a new small-molecule enhancer of the cytostatic effects. |
|||
SMER 28 |
|||
| B7637-50 | ApexBio | 50 mg | EUR 635 |
|
Description: IC50: N/ASMER 28 is a new small-molecule enhancer of the cytostatic effects. |
|||
28-Deoxonimbolide |
|||
| TBZ1212 | ChemNorm | unit | Ask for price |
TRIM28 Tripartite Motif Containing 28 Human Recombinant Protein |
|||
| PROTQ13263 | BosterBio | Regular: 20ug | EUR 317 |
|
Description: TRIM28 Human Recombinant produced in E. Coli is a single polypeptide chain containing 460 amino acids (366-802) and having a molecular mass of 48.7 kDa.;TRIM28 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Recombinant Trypanosoma Brucei PARPB Protein (aa 28-123) |
|||
| VAng-Wyb8133-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2814 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide B-alpha protein, recombinant protein. |
|||
Recombinant Trypanosoma Brucei PARPB Protein (aa 28-123) |
|||
| VAng-Wyb8133-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2016 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide B-alpha protein, recombinant protein. |
|||
Recombinant Trypanosoma Brucei PARPB Protein (aa 28-123) |
|||
| VAng-Wyb8133-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1398 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide B-alpha protein, recombinant protein. |
|||
Recombinant Trypanosoma Brucei PROA Protein (aa 28-93) |
|||
| VAng-Wyb8152-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2649 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide protein, recombinant protein. |
|||
Recombinant Trypanosoma Brucei PROA Protein (aa 28-93) |
|||
| VAng-Wyb8152-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1879 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide protein, recombinant protein. |
|||
Recombinant Trypanosoma Brucei PROA Protein (aa 28-93) |
|||
| VAng-Wyb8152-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1301 |
|
Description: Trypanosoma Brucei brucei Procyclic form-specific polypeptide protein, recombinant protein. |
|||
Recombinant Mycobacterium Tuberculosis Rv2011c Protein (aa 28-143) |
|||
| VAng-Yyj0692-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1454 |
|
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv2011c/MT2066 (Rv2011c, MT2066), recombinant protein. |
|||
Recombinant Mycobacterium Tuberculosis Rv3786c Protein (aa 28-407) |
|||
| VAng-Yyj0754-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2238 |
|
Description: Mycobacterium Tuberculosis Uncharacterized protein Rv3786c/MT3894 (Rv3786c, MT3894), recombinant protein. |
|||
Recombinant Mycobacterium Leprae lprB Protein (aa 28-188) |
|||
| VAng-Yyj1725-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1594 |
|
Description: Mycobacterium Leprae Putative lipoprotein lprB (lprB), recombinant protein. |
|||
Recombinant Mycobacterium Smegmatis MSMEG_5130 Protein (aa 28-627) |
|||
| VAng-Yyj4733-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Probable monoacyl phosphatidylinositol tetramannoside-binding protein LpqW (MSMEG_5130), recombinant protein. |
|||
Recombinant Mycobacterium Smegmatis mspA Protein (aa 28-211) |
|||
| VAng-Yyj4987-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3377 |
|
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Porin MspA (mspA), recombinant protein. |
|||
Recombinant Mycobacterium Smegmatis mspA Protein (aa 28-211) |
|||
| VAng-Yyj4987-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2415 |
|
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Porin MspA (mspA), recombinant protein. |
|||
Recombinant Mycobacterium Smegmatis mspA Protein (aa 28-211) |
|||
| VAng-Yyj4987-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1645 |
|
Description: Mycobacterium Smegmatis (strain ATCC 700084 / mc(2)155) Porin MspA (mspA), recombinant protein. |
|||
Recombinant HPV-28 E2 (aa 1-376) Protein |
|||
| VAng-Wyb3132-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4587 |
|
Description: Human papillomavirus type 28 Regulatory protein E2, recombinant protein. |
|||
Recombinant HPV-28 E2 (aa 1-376) Protein |
|||
| VAng-Wyb3132-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3239 |
|
Description: Human papillomavirus type 28 Regulatory protein E2, recombinant protein. |
|||
Recombinant HPV-28 E2 (aa 1-376) Protein |
|||
| VAng-Wyb3132-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2209 |
|
Description: Human papillomavirus type 28 Regulatory protein E2, recombinant protein. |
|||
Recombinant HPV-28 E4 (aa 1-99) Protein |
|||
| VAng-Wyb3133-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2840 |
|
Description: Human papillomavirus type 28 Probable protein E4, recombinant protein. |
|||
Recombinant HPV-28 E4 (aa 1-99) Protein |
|||
| VAng-Wyb3133-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2030 |
|
Description: Human papillomavirus type 28 Probable protein E4, recombinant protein. |
|||
Recombinant HPV-28 E4 (aa 1-99) Protein |
|||
| VAng-Wyb3133-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1398 |
|
Description: Human papillomavirus type 28 Probable protein E4, recombinant protein. |
|||
Recombinant HPV-28 E6 (aa 1-146) Protein |
|||
| VAng-Wyb3134-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3129 |
|
Description: Human papillomavirus type 28 protein E6, recombinant protein. |
|||
Recombinant HPV-28 E6 (aa 1-146) Protein |
|||
| VAng-Wyb3134-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2236 |
|
Description: Human papillomavirus type 28 protein E6, recombinant protein. |
|||
Recombinant HPV-28 E6 (aa 1-146) Protein |
|||
| VAng-Wyb3134-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1549 |
|
Description: Human papillomavirus type 28 protein E6, recombinant protein. |
|||
Recombinant HPV-28 E7 (aa 1-87) Protein |
|||
| VAng-Wyb3135-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2785 |
|
Description: Human papillomavirus type 28 protein E7, recombinant protein. |
|||
Recombinant HPV-28 E7 (aa 1-87) Protein |
|||
| VAng-Wyb3135-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1975 |
|
Description: Human papillomavirus type 28 protein E7, recombinant protein. |
|||
Recombinant HPV-28 E7 (aa 1-87) Protein |
|||
| VAng-Wyb3135-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1370 |
|
Description: Human papillomavirus type 28 protein E7, recombinant protein. |
|||
Recombinant HPV-28 L2 (aa 1-473) Protein |
|||
| VAng-Wyb3137-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5205 |
|
Description: Human papillomavirus type 28 Minor capsid protein L2, recombinant protein. |
|||
Recombinant HPV-28 L2 (aa 1-473) Protein |
|||
| VAng-Wyb3137-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3679 |
|
Description: Human papillomavirus type 28 Minor capsid protein L2, recombinant protein. |
|||
Recombinant HPV-28 L2 (aa 1-473) Protein |
|||
| VAng-Wyb3137-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2511 |
|
Description: Human papillomavirus type 28 Minor capsid protein L2, recombinant protein. |
|||
Recombinant Schizosaccharomyces Pombe tim50 Protein (aa 28-452) |
|||
| VAng-Yyj5949-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Schizosaccharomyces Pombe (strain 972 / ATCC 24843) (Fission yeast) Mitochondrial import inner membrane translocase subunit tim50 (tim50), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb2034c Protein (aa 28-143) |
|||
| VAng-Yyj2888-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2940 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb2034c (Mb2034c), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb2034c Protein (aa 28-143) |
|||
| VAng-Yyj2888-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2109 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb2034c (Mb2034c), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb2034c Protein (aa 28-143) |
|||
| VAng-Yyj2888-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1454 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb2034c (Mb2034c), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb1845 Protein (aa 28-221) |
|||
| VAng-Yyj3040-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3432 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb1845 (Mb1845), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb1845 Protein (aa 28-221) |
|||
| VAng-Yyj3040-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2456 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb1845 (Mb1845), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb1845 Protein (aa 28-221) |
|||
| VAng-Yyj3040-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1673 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb1845 (Mb1845), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb3815c Protein (aa 28-407) |
|||
| VAng-Yyj3128-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4614 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb3815c (Mb3815c), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb3815c Protein (aa 28-407) |
|||
| VAng-Yyj3128-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3268 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb3815c (Mb3815c), recombinant protein. |
|||
Recombinant Mycobacterium Bovis Mb3815c Protein (aa 28-407) |
|||
| VAng-Yyj3128-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2236 |
|
Description: Mycobacterium Bovis Uncharacterized protein Mb3815c (Mb3815c), recombinant protein. |
|||
Recombinant Escherichia coli lptA Protein (aa 28-185) |
|||
| VAng-Lsx02468-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3294 |
|
Description: Escherichia coli Lipopolysaccharide export system protein LptA, recombinant protein. |
|||
Recombinant Escherichia coli lptA Protein (aa 28-185) |
|||
| VAng-Lsx02468-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2113 |
|
Description: Escherichia coli Lipopolysaccharide export system protein LptA, recombinant protein. |
|||
Recombinant Escherichia coli lptA Protein (aa 28-185) |
|||
| VAng-Lsx02468-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 573 |
|
Description: Escherichia coli Lipopolysaccharide export system protein LptA, recombinant protein. |
|||
Recombinant Haemophilus Influenzae hifB Protein (aa 28-241) |
|||
| VAng-Lsx03394-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3569 |
|
Description: Haemophilus Influenzae Chaperone protein hifB, recombinant protein. |
|||
Recombinant Haemophilus Influenzae hifB Protein (aa 28-241) |
|||
| VAng-Lsx03394-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2553 |
|
Description: Haemophilus Influenzae Chaperone protein hifB, recombinant protein. |
|||
Recombinant Haemophilus Influenzae hifB Protein (aa 28-241) |
|||
| VAng-Lsx03394-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1728 |
|
Description: Haemophilus Influenzae Chaperone protein hifB, recombinant protein. |
|||
Recombinant Shigella Flexneri fruL Protein (aa 1-28) |
|||
| VAng-Lsx07766-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2401 |
|
Description: Shigella Flexneri Putative fruR/shl operon leader peptide, recombinant protein. |
|||
Recombinant Shigella Flexneri fruL Protein (aa 1-28) |
|||
| VAng-Lsx07766-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1714 |
|
Description: Shigella Flexneri Putative fruR/shl operon leader peptide, recombinant protein. |
|||
Recombinant Shigella Flexneri fruL Protein (aa 1-28) |
|||
| VAng-Lsx07766-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1191 |
|
Description: Shigella Flexneri Putative fruR/shl operon leader peptide, recombinant protein. |
|||
Recombinant Shigella Flexneri hybA Protein (aa 28-328) |
|||
| VAng-Lsx07858-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4119 |
|
Description: Shigella Flexneri Hydrogenase-2 operon protein hybA, recombinant protein. |
|||
Recombinant Shigella Flexneri hybA Protein (aa 28-328) |
|||
| VAng-Lsx07858-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2909 |
|
Description: Shigella Flexneri Hydrogenase-2 operon protein hybA, recombinant protein. |
|||
Recombinant Shigella Flexneri hybA Protein (aa 28-328) |
|||
| VAng-Lsx07858-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1989 |
|
Description: Shigella Flexneri Hydrogenase-2 operon protein hybA, recombinant protein. |
|||
Recombinant Shigella Flexneri leuL Protein (aa 1-28) |
|||
| VAng-Lsx07886-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2401 |
|
Description: Shigella Flexneri Leu operon leader peptide, recombinant protein. |
|||
Recombinant Shigella Flexneri leuL Protein (aa 1-28) |
|||
| VAng-Lsx07886-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 1714 |
|
Description: Shigella Flexneri Leu operon leader peptide, recombinant protein. |
|||
Recombinant Shigella Flexneri leuL Protein (aa 1-28) |
|||
| VAng-Lsx07886-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1191 |
|
Description: Shigella Flexneri Leu operon leader peptide, recombinant protein. |
|||
Recombinant Shigella Flexneri nrfC Protein (aa 28-223) |
|||
| VAng-Lsx07990-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3445 |
|
Description: Shigella Flexneri Protein nrfC, recombinant protein. |
|||
Recombinant Shigella Flexneri nrfC Protein (aa 28-223) |
|||
| VAng-Lsx07990-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2470 |
|
Description: Shigella Flexneri Protein nrfC, recombinant protein. |
|||
Proliferating cell nuclear antigen straight interacts with androgen receptor and enhances androgen receptor‑mediated signaling
Androgen receptor (AR) and/or its constitutively lively splicing variants (AR‑Vs), reminiscent of AR‑V7 and ARv567es, is required for prostate most cancers cell development and survival, and most cancers development. Proliferating cell nuclear antigen (PCNA) is preferentially overexpressed in all cancers and executes its capabilities by way of interplay with quite a few accomplice proteins. The goal of the current research was to research the potential position of PCNA within the regulation of AR exercise.
An equivalent consensus sequence of the PCNA‑interacting protein‑field (PIP‑field) was recognized on the N‑terminus of human, mouse and rat AR proteins. It was discovered that PCNA complexes with the total‑size AR (AR‑FL) and AR‑V7, which will be attenuated by the small molecule PIP‑field inhibitor, T2AA. PCNA additionally complexes with ARv567es and recombinant AR protein. The PCNA inhibitors, PCNA‑I1S and T2AA, inhibited AR transcriptional exercise and the expression of AR goal genes in LNCaP‑AI and 22Rv1 cells, however not in AR‑detrimental PC‑three cells. The knockdown of PCNA expression lowered dihydrotestosterone‑stimulated AR transcriptional exercise and abolished the inhibitory impact of PCNA‑I1S on AR exercise. The PCNA inhibitor, PCNA‑I1, exerted additive development inhibitory results with androgen deprivation and enzalutamide in cells expressing AR‑FL or AR‑FL/AR‑V7, however not in AR‑detrimental PC‑three cells.
Lastly, R9‑AR‑PIP, a small peptide mimicking AR PIP‑field, was discovered to bind to GFP‑PCNA at Okd of two.73 µM and inhibit the expression of AR goal genes, AR transcriptional exercise and the expansion of AR‑expressing cells. On the entire, these information strongly recommend that AR is a PCNA accomplice protein and interacts with PCNA through the PIP‑field and that focusing on the PCNA‑AR interplay might characterize an progressive and selective therapeutic technique towards prostate most cancers, notably castration‑resistant prostate cancers overexpressing constitutively lively AR‑Vs.
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells successfully remove human glioblastoma
Targets: The rising success of Chimeric Antigen Receptor (CAR) T cell remedy in haematological malignancies is reinvigorating its software in lots of different most cancers varieties and with renewed concentrate on its software to strong tumors. We current a novel CAR towards glioblastoma, an aggressive, malignant glioma, with a dismal survival charge for which therapy choices have remained unchanged for over a decade.
Strategies: We use the human Retained Show (ReD) antibody platform (Myrio Therapeutics) to establish a novel single-chain variable fragment (scFv) that recognises epidermal development issue receptor mutant variant III (EGFRvIII), a typical and tumor-specific mutation present in glioblastoma. We use each in vitro useful assays and an in vivo orthotopic xenograft mannequin of glioblastoma to look at the operate of our novel CAR, known as GCT02, focused utilizing murine CAR T cells.
Outcomes: Our EGFRvIII-specific scFv was discovered to be of a lot increased affinity than reported comparators reverse-engineered from monoclonal antibodies. Regardless of the upper affinity, GCT02 CAR T cells kill equivalently however secrete decrease quantities of cytokine. As well as, GCT02-CAR T cells additionally mediate fast and full tumor elimination in vivo.
Conclusion: We current a novel EGFRvIII-specific CAR, with efficient antitumor capabilities each in in vitro and in a xenograft mannequin of human glioblastoma.
ZDHHC8P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701071 | ABM | 1.0 ug DNA | EUR 450 |
FLJ26850 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701077 | ABM | 1.0 ug DNA | EUR 450 |
OCLM Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701083 | ABM | 1.0 ug DNA | EUR 450 |
LINC00314 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701089 | ABM | 1.0 ug DNA | EUR 450 |
GSTTP1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701095 | ABM | 1.0 ug DNA | EUR 450 |
LOC285679 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701101 | ABM | 1.0 ug DNA | EUR 450 |
VN1R3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701107 | ABM | 1.0 ug DNA | EUR 450 |
MT1DP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701119 | ABM | 1.0 ug DNA | EUR 450 |
LINC00313 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701131 | ABM | 1.0 ug DNA | EUR 450 |
LOC222699 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701143 | ABM | 1.0 ug DNA | EUR 450 |
LINC00161 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701149 | ABM | 1.0 ug DNA | EUR 450 |
LOC440419 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701155 | ABM | 1.0 ug DNA | EUR 450 |
KCNQ1DN Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701161 | ABM | 1.0 ug DNA | EUR 450 |
RBMS1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701179 | ABM | 1.0 ug DNA | EUR 450 |
MIR22HG Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701185 | ABM | 1.0 ug DNA | Ask for price |
C22orf34 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701191 | ABM | 1.0 ug DNA | EUR 450 |
ZNF663 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701197 | ABM | 1.0 ug DNA | EUR 450 |
AKR1CL1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701203 | ABM | 1.0 ug DNA | EUR 450 |
HMGB3P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701209 | ABM | 1.0 ug DNA | EUR 450 |
ASIP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701215 | ABM | 1.0 ug DNA | EUR 450 |
LOC149950 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701221 | ABM | 1.0 ug DNA | EUR 450 |
BOLA2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701227 | ABM | 1.0 ug DNA | EUR 450 |
LOC441108 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701233 | ABM | 1.0 ug DNA | EUR 450 |
FLJ16126 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701239 | ABM | 1.0 ug DNA | EUR 450 |
LOC728032 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701245 | ABM | 1.0 ug DNA | EUR 450 |
C21orf67 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701257 | ABM | 1.0 ug DNA | EUR 450 |
TP53TG3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701263 | ABM | 1.0 ug DNA | EUR 450 |
OSTBETA Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701269 | ABM | 1.0 ug DNA | EUR 450 |
FLJ33360 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701275 | ABM | 1.0 ug DNA | EUR 450 |
LOC441208 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701281 | ABM | 1.0 ug DNA | EUR 450 |
C12orf36 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701287 | ABM | 1.0 ug DNA | EUR 450 |
LOC153684 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701293 | ABM | 1.0 ug DNA | EUR 450 |
LOC399900 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701299 | ABM | 1.0 ug DNA | EUR 450 |
LOC149134 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701305 | ABM | 1.0 ug DNA | EUR 450 |
LINC00173 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701317 | ABM | 1.0 ug DNA | EUR 450 |
LITAF Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701323 | ABM | 1.0 ug DNA | EUR 450 |
HIST1H2AI Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701329 | ABM | 1.0 ug DNA | EUR 450 |
LOC440905 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701335 | ABM | 1.0 ug DNA | EUR 450 |
LOC339535 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701341 | ABM | 1.0 ug DNA | EUR 450 |
LOC643210 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701347 | ABM | 1.0 ug DNA | EUR 450 |
LOC440337 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701353 | ABM | 1.0 ug DNA | EUR 450 |
BEX1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701359 | ABM | 1.0 ug DNA | EUR 450 |
HIST2H2AA4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701365 | ABM | 1.0 ug DNA | EUR 450 |
LPAL2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701371 | ABM | 1.0 ug DNA | EUR 450 |
LOC340094 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701377 | ABM | 1.0 ug DNA | EUR 450 |
LINC00574 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701383 | ABM | 1.0 ug DNA | EUR 450 |
CIB2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701389 | ABM | 1.0 ug DNA | EUR 450 |
SNX12 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701401 | ABM | 1.0 ug DNA | EUR 450 |
FLJ44006 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701407 | ABM | 1.0 ug DNA | EUR 450 |
C15orf37 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701413 | ABM | 1.0 ug DNA | EUR 450 |
PLAC2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701419 | ABM | 1.0 ug DNA | EUR 450 |
BTG2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701425 | ABM | 1.0 ug DNA | EUR 450 |
FLJ40448 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701449 | ABM | 1.0 ug DNA | EUR 450 |
CIB3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701455 | ABM | 1.0 ug DNA | EUR 450 |
PRDX5 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701461 | ABM | 1.0 ug DNA | EUR 450 |
FLJ45256 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701467 | ABM | 1.0 ug DNA | EUR 450 |
C21orf67 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701473 | ABM | 1.0 ug DNA | EUR 450 |
LINC00477 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701479 | ABM | 1.0 ug DNA | EUR 450 |
LOC348262 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701491 | ABM | 1.0 ug DNA | EUR 450 |
SHISA4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701497 | ABM | 1.0 ug DNA | EUR 450 |
LOC400707 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701503 | ABM | 1.0 ug DNA | EUR 450 |
FLJ41423 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701509 | ABM | 1.0 ug DNA | EUR 450 |
FLJ46257 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701515 | ABM | 1.0 ug DNA | EUR 450 |
FKSG83 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701521 | ABM | 1.0 ug DNA | EUR 450 |
FLJ25328 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701527 | ABM | 1.0 ug DNA | EUR 450 |
LOC84931 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701533 | ABM | 1.0 ug DNA | EUR 450 |
LOC389791 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701539 | ABM | 1.0 ug DNA | EUR 450 |
LOC338809 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701545 | ABM | 1.0 ug DNA | EUR 450 |
LOC441251 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701557 | ABM | 1.0 ug DNA | EUR 450 |
INSL6 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701563 | ABM | 1.0 ug DNA | EUR 450 |
C1orf222 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701569 | ABM | 1.0 ug DNA | EUR 450 |
SFTPA2B Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701575 | ABM | 1.0 ug DNA | EUR 450 |
CCDC102B Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701599 | ABM | 1.0 ug DNA | EUR 450 |
C1QTNF3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701605 | ABM | 1.0 ug DNA | EUR 450 |
OTOGL Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701611 | ABM | 1.0 ug DNA | EUR 450 |
LHPP Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701617 | ABM | 1.0 ug DNA | EUR 450 |
TICAM2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701623 | ABM | 1.0 ug DNA | EUR 450 |
CHMP4A Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701629 | ABM | 1.0 ug DNA | EUR 450 |
ALKBH3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701635 | ABM | 1.0 ug DNA | EUR 450 |
FBP2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701641 | ABM | 1.0 ug DNA | EUR 450 |
CLEC12A Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701647 | ABM | 1.0 ug DNA | EUR 450 |
OR2C1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701653 | ABM | 1.0 ug DNA | EUR 450 |
TMEM182 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701659 | ABM | 1.0 ug DNA | EUR 450 |
LOC339524 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701665 | ABM | 1.0 ug DNA | EUR 450 |
SEPSECS Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701671 | ABM | 1.0 ug DNA | EUR 450 |
Selv Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701677 | ABM | 1.0 ug DNA | EUR 450 |
GPR87 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701683 | ABM | 1.0 ug DNA | EUR 450 |
ASTN2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701689 | ABM | 1.0 ug DNA | EUR 450 |
MAGEB3 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701695 | ABM | 1.0 ug DNA | EUR 450 |
SSTr4 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV701713 | ABM | 1.0 ug DNA | EUR 450 |